Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech venture capital
Biotech
Boston biotech banks $90M for next-gen bispecifics
Led by RA Capital, the $90 million series A will help Bambusa build out a pipeline of next-gen bispecific antibodies targeting I&I conditions.
Gabrielle Masson
Feb 14, 2025 10:10am
Fierce Biotech Fundraising Tracker: Bambusa, Newleos & more
Feb 14, 2025 7:00am
Sanofi-backed radiopharma AdvanCell secures $112M series C
Feb 3, 2025 9:00am
Atalanta loads crossbow with $97M, 2 Big Pharmas in tow
Jan 28, 2025 7:00am
Windward generates $200M with Novo Holdings, OrbiMed in tow
Jan 10, 2025 10:02am
Ouro launches with $120M and a clinical-stage T-cell engager
Jan 10, 2025 6:00am